Education
About Us
Working with TipRanks
Follow Us
C4 Therapeutics, Inc. (CCCC)
NASDAQ:CCCC
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 35.58M | $ 20.76M | $ 31.10M | $ 45.78M | $ 33.20M |
| Gross Profit | $ 35.58M | $ 13.02M | $ 31.10M | $ 45.78M | $ -45.24M |
| Operating Income | $ -119.61M | $ -139.03M | $ -129.53M | $ -82.13M | $ -60.45M |
| EBITDA | $ -103.37M | $ -122.10M | $ -124.28M | $ -80.25M | $ -58.83M |
| Net Income | $ -105.32M | $ -132.49M | $ -128.18M | $ -83.89M | $ -66.33M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 244.90M | $ 253.68M | $ 276.15M | $ 309.28M | $ 371.69M |
| Total Assets | $ 349.60M | $ 376.45M | $ 430.84M | $ 506.76M | $ 400.14M |
| Total Debt | $ 65.76M | $ 70.98M | $ 87.15M | $ 42.88M | $ 22.92M |
| Net Debt | $ 10.26M | $ -55.61M | $ 57.40M | $ -33.24M | $ -158.81M |
| Total Liabilities | $ 133.62M | $ 130.34M | $ 141.61M | $ 117.16M | $ 119.35M |
| Stockholders' Equity | $ 215.99M | $ 246.11M | $ 289.23M | $ 389.61M | $ 280.79M |
| Cash Flow | |||||
| Free Cash Flow | $ -65.34M | $ -108.55M | $ -111.44M | $ -88.24M | $ -67.90M |
| Operating Cash Flow | $ -65.16M | $ -106.84M | $ -105.94M | $ -86.97M | $ -67.25M |
| Investing Cash Flow | $ -51.27M | $ 158.35M | $ 58.42M | $ -189.34M | $ -190.50M |
| Financing Cash Flow | $ 45.34M | $ 45.49M | $ 1.15M | $ 171.40M | $ 348.93M |